Disclosure Of Entity's Operating Segments [Text Block]

Egetis Therapeutics - Filing #701621

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
38 243 SEK
40 662 SEK
Tax expense (income)
- SEK
- SEK
Profit (loss) before tax
104 542 SEK
178 024 SEK
Profit (loss)
104 542 SEK
178 024 SEK
Assets
569 269 SEK
717 000 SEK
Cash flows from (used in) operating activities
130 110 SEK
134 639 SEK
Cash flows from (used in) investing activities
5 957 SEK
59 543 SEK
Cash flows from (used in) financing activities
8 902 SEK
228 405 SEK
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.